These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 21898349)
1. Localized expression of tenascin in systemic sclerosis-associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3. Brissett M; Veraldi KL; Pilewski JM; Medsger TA; Feghali-Bostwick CA Arthritis Rheum; 2012 Jan; 64(1):272-80. PubMed ID: 21898349 [TBL] [Abstract][Full Text] [Related]
2. Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis. Del Galdo F; Sotgia F; de Almeida CJ; Jasmin JF; Musick M; Lisanti MP; Jiménez SA Arthritis Rheum; 2008 Sep; 58(9):2854-65. PubMed ID: 18759267 [TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathways. Hsu E; Feghali-Bostwick CA Am J Pathol; 2008 Jun; 172(6):1580-90. PubMed ID: 18467708 [TBL] [Abstract][Full Text] [Related]
4. Depletion of protein kinase Cepsilon in normal and scleroderma lung fibroblasts has opposite effects on tenascin expression. Tourkina E; Hoffman S; Fenton JW; Lipsitz S; Silver RM; Ludwicka-Bradley A Arthritis Rheum; 2001 Jun; 44(6):1370-81. PubMed ID: 11407697 [TBL] [Abstract][Full Text] [Related]
5. The membrane-associated adaptor protein DOK5 is upregulated in systemic sclerosis and associated with IGFBP-5-induced fibrosis. Yasuoka H; Yamaguchi Y; Feghali-Bostwick CA PLoS One; 2014; 9(2):e87754. PubMed ID: 24551065 [TBL] [Abstract][Full Text] [Related]
6. Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development. Lambrecht S; Smith V; De Wilde K; Coudenys J; Decuman S; Deforce D; De Keyser F; Elewaut D Arthritis Rheumatol; 2014 Feb; 66(2):418-27. PubMed ID: 24504814 [TBL] [Abstract][Full Text] [Related]
7. NADPH oxidase-mediated induction of reactive oxygen species and extracellular matrix deposition by insulin-like growth factor binding protein-5. Yasuoka H; Garrett SM; Nguyen XX; Artlett CM; Feghali-Bostwick CA Am J Physiol Lung Cell Mol Physiol; 2019 Apr; 316(4):L644-L655. PubMed ID: 30810066 [TBL] [Abstract][Full Text] [Related]
11. Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension. Hsu E; Shi H; Jordan RM; Lyons-Weiler J; Pilewski JM; Feghali-Bostwick CA Arthritis Rheum; 2011 Mar; 63(3):783-94. PubMed ID: 21360508 [TBL] [Abstract][Full Text] [Related]
12. Suppressive Regulation by MFG-E8 of Latent Transforming Growth Factor β-Induced Fibrosis via Binding to αv Integrin: Significance in the Pathogenesis of Fibrosis in Systemic Sclerosis. Fujiwara C; Uehara A; Sekiguchi A; Uchiyama A; Yamazaki S; Ogino S; Yokoyama Y; Torii R; Hosoi M; Suto C; Tsunekawa K; Murakami M; Ishikawa O; Motegi SI Arthritis Rheumatol; 2019 Feb; 71(2):302-314. PubMed ID: 30175895 [TBL] [Abstract][Full Text] [Related]
13. Anti-fibrotic effects of pirfenidone by interference with the hedgehog signalling pathway in patients with systemic sclerosis-associated interstitial lung disease. Xiao H; Zhang GF; Liao XP; Li XJ; Zhang J; Lin H; Chen Z; Zhang X Int J Rheum Dis; 2018 Feb; 21(2):477-486. PubMed ID: 29316328 [TBL] [Abstract][Full Text] [Related]
14. Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis. Ruiz XD; Mlakar LR; Yamaguchi Y; Su Y; Larregina AT; Pilewski JM; Feghali-Bostwick CA PLoS One; 2012; 7(8):e43049. PubMed ID: 22900087 [TBL] [Abstract][Full Text] [Related]
15. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis. Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424 [TBL] [Abstract][Full Text] [Related]
16. The transcription factor GLI2 as a downstream mediator of transforming growth factor-β-induced fibroblast activation in SSc. Liang R; Šumová B; Cordazzo C; Mallano T; Zhang Y; Wohlfahrt T; Dees C; Ramming A; Krasowska D; Michalska-Jakubus M; Distler O; Schett G; Šenolt L; Distler JH Ann Rheum Dis; 2017 Apr; 76(4):756-764. PubMed ID: 27793816 [TBL] [Abstract][Full Text] [Related]
17. Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis. Hamaguchi Y; Fujimoto M; Matsushita T; Hasegawa M; Takehara K; Sato S J Rheumatol; 2008 Dec; 35(12):2363-71. PubMed ID: 19004037 [TBL] [Abstract][Full Text] [Related]
18. Tenascin-C drives persistence of organ fibrosis. Bhattacharyya S; Wang W; Morales-Nebreda L; Feng G; Wu M; Zhou X; Lafyatis R; Lee J; Hinchcliff M; Feghali-Bostwick C; Lakota K; Budinger GR; Raparia K; Tamaki Z; Varga J Nat Commun; 2016 Jun; 7():11703. PubMed ID: 27256716 [TBL] [Abstract][Full Text] [Related]
19. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis. Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144 [TBL] [Abstract][Full Text] [Related]
20. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma. Zhou X; Tan FK; Guo X; Arnett FC Arthritis Rheum; 2006 Aug; 54(8):2626-31. PubMed ID: 16871529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]